Commentary - (2022) Volume 8, Issue 6
Received: 20-Nov-2021, Manuscript No. IPCPDR-21-10618; Editor assigned: 22-Nov-2021, Pre QC No. IPCPDR-21-10618 (PQ); Reviewed: 06-Dec-2021, QC No. IPCPDR-21-10618; Revised: 10-Oct-2022, Manuscript No. IPCPDR-21-10618 (R); Published: 17-Oct-2022, DOI: 10.36648/2472-0143.8.6.22
Concerns relating to the skin are common reasons for parents to seek medical care for their children. Data from several sources indicate that up to 20% of child visits to pediatricians or family physicians involve a dermatologic problem as the primary reason for the visit, a secondary concern, or an incidental finding on physical examination. The volume of skin related concerns and the supply demand crunch for dermatologic referrals mandate that primary care physicians who care for children are prepared to recognize, diagnose, and treat common cutaneous disorders. Your child might see a dermatologist if he has rashes, eczema, psoriasis, birthmarks and acne. A dermatologist can also look at any moles on your child's body to check for problems (moles can turn into melanoma, but this rarely happens in childhood). When the skin is actively inflamed, anti-inflammatory therapy is necessary. Topical steroids are still considered first line antiinflammatory therapy for the treatment of atopic dermatitis in children. Choose the lowest potency/strength topical steroid which will be effective. Chronic pruritus associated with systemic diseases in the pediatric population has been infrequently addressed in the literature. This review focuses on chronic pruritus presenting without cutaneous manifestations. Common systemic etiologies include diseases with hepatic, renal, and hematologic origins. This encompasses several congenital liver disorders, End Stage Renal Disease (ESRD), and lymph proliferative disorders such as Hodgkin's lymphoma. In this paper, an expert panel describes the clinical characteristics, pathophysiology, and therapeutic treatment ladders for chronic pruritus associated with the aforementioned systemic etiologies. Novel therapies are also reviewed. Our aim is to shed light on this unexplored area of pediatric dermatology and instigate further research. Acne is a common skin condition that may be treated by both dermatologists and pediatricians. However, the treatments provided by dermatologists and pediatricians may differ. We aimed to describe acne therapy prescribing patterns of dermatologists and pediatricians. Topical steroids should be used no more than twice daily. Applied in combination with an emollient. As inflammation subsides, attempt to decrease the strength/potency of topical steroid and/or frequency of use. When inflammation recurs, restart topical steroid. We performed a population based, cross sectional analysis using data from the national ambulatory medical care survey from 2006 to 2016 for pediatric patients (age ≤ 18 years). There were approximately 30.5 million (weighted) outpatient acne visits between 2006 and 2016 for pediatric patients; 52% of visits were conducted by dermatologists, 29% by pediatricians, and 19% by other providers. Compared to pediatricians, dermatologists saw older patients (mean age 15.5 ± 0.12 vs. 13.5 ± 0.35; P<.001), as well as a higher proportion of white patients (92.5% vs. 76.3%; P<.001), non-hispanic patients (89.5% vs. 81.6%; P<.001), and patients with private insurance (84.6% vs. 67.8%; P<.001). Compared to patients seen by dermatologists, patients seen by pediatricians were 68% less likely to receive topical retinoid (aOR 0.32, 95% CI 0.22-0.46), 38% less likely to receive topical antibiotics (aOR 0.62, 95% CI 0.41-0.95), and 48% less likely to receive oral antibiotics (adjusted aOR 0.52, 95% CI 0.36-0.75). Our findings demonstrate that pediatricians prescribe topical retinoids, topical antibiotics, and oral antibiotics less frequently compared to dermatologists. It is important to understand these differences in prescribing patterns for acne and to identify potential educational gaps.
Citation: John S (2022) Pediatric Dermatology: Study Based on Population. Clin Pediatr Dermatol. 8:22
Copyright: © 2022 John S. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
